<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Guillem Hurault</title><link>https://ghurault.github.io/</link><atom:link href="https://ghurault.github.io/index.xml" rel="self" type="application/rss+xml"/><description>Guillem Hurault</description><generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><lastBuildDate>Wed, 24 Aug 2022 11:30:00 +0100</lastBuildDate><image><url>https://ghurault.github.io/media/sharing.jpeg</url><title>Guillem Hurault</title><link>https://ghurault.github.io/</link></image><item><title>Applications of Machine Learning in medical research</title><link>https://ghurault.github.io/talk/applications-of-machine-learning-in-medical-research/</link><pubDate>Wed, 24 Aug 2022 11:30:00 +0100</pubDate><guid>https://ghurault.github.io/talk/applications-of-machine-learning-in-medical-research/</guid><description/></item><item><title>Evolution of Eczema, Wheeze and Rhinitis from Infancy to Early Adulthood: Four Birth Cohort Studies</title><link>https://ghurault.github.io/publication/2022-haider-evolution/</link><pubDate>Thu, 09 Jun 2022 00:00:00 +0000</pubDate><guid>https://ghurault.github.io/publication/2022-haider-evolution/</guid><description/></item><item><title>Making the most of eczema data for prediction, inference and treatment recommendation</title><link>https://ghurault.github.io/talk/making-the-most-of-eczema-data-for-prediction-inference-and-treatment-recommendation/</link><pubDate>Tue, 07 Jun 2022 13:00:00 +0100</pubDate><guid>https://ghurault.github.io/talk/making-the-most-of-eczema-data-for-prediction-inference-and-treatment-recommendation/</guid><description/></item><item><title>PhD project</title><link>https://ghurault.github.io/project/phd/</link><pubDate>Wed, 01 Jun 2022 00:00:00 +0000</pubDate><guid>https://ghurault.github.io/project/phd/</guid><description>&lt;h2 id="abstract">Abstract&lt;/h2>
&lt;p>Atopic Dermatitis (AD, eczema) is a common inflammatory skin disease, characterised by dry and itchy skin.
AD cannot be cured, but its long-term outcomes can be managed with treatments.
Given the heterogeneity in patients&amp;rsquo; responses to treatment, designing personalised rather than &amp;ldquo;one-size-fits-all&amp;rdquo; treatment strategies is of high clinical relevance.
In this thesis, we aim to pave the way towards a data-driven personalised management of AD severity, whereby severity data would be collected automatically from photographs without the need for patients to visit a clinic, be used to predict the evolution of AD severity, and generate personalised treatment recommendations.&lt;/p>
&lt;p>First, we developed EczemaNet&lt;sup id="fnref:1">&lt;a href="#fn:1" class="footnote-ref" role="doc-noteref">1&lt;/a>&lt;/sup>, a computer vision pipeline using convolution neural networks that detects areas of AD from photographs and then makes probabilistic assessments of AD severity.
EczemaNet was internally validated with a medium-size dataset of images collected in a published clinical trial and demonstrated fair performance.&lt;/p>
&lt;p>Then, we developed models predicting the daily to weekly evolution of AD severity&lt;sup id="fnref:2">&lt;a href="#fn:2" class="footnote-ref" role="doc-noteref">2&lt;/a>&lt;/sup>.
We highlighted the challenges of extracting signals from noisy severity data, with small and practically not significant effects of environmental factors&lt;sup id="fnref:3">&lt;a href="#fn:3" class="footnote-ref" role="doc-noteref">3&lt;/a>&lt;/sup> and biomarkers&lt;sup id="fnref:4">&lt;a href="#fn:4" class="footnote-ref" role="doc-noteref">4&lt;/a>&lt;/sup> on prediction.
We showed the importance of using high-quality measurements of validated and objective (vs subjective) severity scores.
We also stressed the importance of modelling individual severity items rather than aggregate scores, and introduced EczemaPred&lt;sup id="fnref:5">&lt;a href="#fn:5" class="footnote-ref" role="doc-noteref">5&lt;/a>&lt;/sup>, a principled approach to predict AD severity using Bayesian state-space models.
Our models are flexible by design, interpretable and can quantify uncertainty in measurements, parameters and predictions.
The models demonstrated good performance to predict the Patient-Oriented SCOring AD (PO-SCORAD).&lt;/p>
&lt;p>Finally, we generated personalised treatment recommendations using Bayesian decision analysis.
We observed that treatment effects and recommendations could be confounded by the clinical phenotype of patients.
We also pretrained our model using historical data and combined clinical and self-assessments.&lt;/p>
&lt;p>In conclusion, we have demonstrated the feasibility and the challenges of a data-driven personalised management of AD severity.&lt;/p>
&lt;p>&lt;strong>The link to my thesis will be made available soon&lt;/strong>&lt;/p>
&lt;h2 id="references">References&lt;/h2>
&lt;div class="footnotes" role="doc-endnotes">
&lt;hr>
&lt;ol>
&lt;li id="fn:1">
&lt;p>&lt;a href="https://doi.org/10.1007/978-3-030-59861-7_23" target="_blank" rel="noopener">K. Pan, &lt;strong>G. Hurault&lt;/strong>, K. Arulkumaran, H. Williams and R. J. Tanaka,
&amp;ldquo;EczemaNet: Automating Detection and Assessment of Atopic Dermatitis&amp;rdquo;,
&lt;em>International Workshop on Machine Learning in Medical Imaging&lt;/em>, 2020&lt;/a>&amp;#160;&lt;a href="#fnref:1" class="footnote-backref" role="doc-backlink">&amp;#x21a9;&amp;#xfe0e;&lt;/a>&lt;/p>
&lt;/li>
&lt;li id="fn:2">
&lt;p>&lt;a href="https://doi.org/10.1111/cea.13717" target="_blank" rel="noopener">&lt;strong>G. Hurault&lt;/strong>, E. Domínguez-Hüttinger, S. M. Langan, H. C. Williams and R. J. Tanaka,
&amp;ldquo;Personalised prediction of daily eczema severity scores using a mechanistic machine learning model&amp;rdquo;,
&lt;em>Clinical &amp;amp; Experimental Allergy&lt;/em>, vol. 50, no. 11, pp. 1258–1266, 2020&lt;/a>&amp;#160;&lt;a href="#fnref:2" class="footnote-backref" role="doc-backlink">&amp;#x21a9;&amp;#xfe0e;&lt;/a>&lt;/p>
&lt;/li>
&lt;li id="fn:3">
&lt;p>&lt;a href="https://doi.org/10.1002/clt2.12019" target="_blank" rel="noopener">&lt;strong>G. Hurault&lt;/strong>, V. Delorieux, Y-M. Kim, K. Ahn, H. Williams and R. J. Tanaka,
&amp;ldquo;Impact of environmental factors in predicting daily severity scores of atopic dermatitis&amp;rdquo;,
&lt;em>Clinical and Translational Allergy, vol. 11, no. 2&lt;/em>, 2021&lt;/a>&amp;#160;&lt;a href="#fnref:3" class="footnote-backref" role="doc-backlink">&amp;#x21a9;&amp;#xfe0e;&lt;/a>&lt;/p>
&lt;/li>
&lt;li id="fn:4">
&lt;p>&lt;a href="https://doi.org/10.1101/2020.12.02.20242404" target="_blank" rel="noopener">&lt;strong>G. Hurault&lt;/strong>, E. Roekevisch, M.E. Schram, K. Szegedi, S. Kezic, M.A. Middelkamp-Hup, P.I. Spuls and R. J. Tanaka,
&amp;ldquo;Can serum biomarkers predict the outcome of systemic therapy for atopic dermatitis?&amp;rdquo;,
&lt;em>MedRxiv (preprint)&lt;/em>, 2020.&lt;/a>&amp;#160;&lt;a href="#fnref:4" class="footnote-backref" role="doc-backlink">&amp;#x21a9;&amp;#xfe0e;&lt;/a>&lt;/p>
&lt;/li>
&lt;li id="fn:5">
&lt;p>&lt;a href="https://doi.org/10.1002/clt2.12140" target="_blank" rel="noopener">&lt;strong>G. Hurault&lt;/strong>, J-F Stalder, S. Mery, A. Delarue, M. Saint Aroma, G. Josse and R. J. Tanaka,
&amp;ldquo;EczemaPred: A computational framework for personalised prediction of eczema severity dynamics&amp;rdquo;,
&lt;em>Clinical and Translational Allergy&lt;/em>, 2022, vol. 12, no. 3, p. e12140.&lt;/a>&amp;#160;&lt;a href="#fnref:5" class="footnote-backref" role="doc-backlink">&amp;#x21a9;&amp;#xfe0e;&lt;/a>&lt;/p>
&lt;/li>
&lt;/ol>
&lt;/div></description></item><item><title>EczemaPred: A computational framework for personalised prediction of eczema severity dynamics</title><link>https://ghurault.github.io/publication/2022-hurault-eczemapred/</link><pubDate>Mon, 28 Mar 2022 00:00:00 +0000</pubDate><guid>https://ghurault.github.io/publication/2022-hurault-eczemapred/</guid><description/></item><item><title>Detecting eczema areas in digital images: an impossible task?</title><link>https://ghurault.github.io/publication/2022-hurault-detecting/</link><pubDate>Wed, 09 Mar 2022 00:00:00 +0000</pubDate><guid>https://ghurault.github.io/publication/2022-hurault-detecting/</guid><description/></item><item><title>Can serum biomarkers predict the outcome of systemic immunosuppressive therapy in adult atopic dermatitis patients?</title><link>https://ghurault.github.io/publication/2022-hurault-serum/</link><pubDate>Fri, 07 Jan 2022 12:00:00 +0000</pubDate><guid>https://ghurault.github.io/publication/2022-hurault-serum/</guid><description/></item><item><title>EczemaPred</title><link>https://ghurault.github.io/project/eczemapred/</link><pubDate>Mon, 11 Oct 2021 00:00:00 +0000</pubDate><guid>https://ghurault.github.io/project/eczemapred/</guid><description/></item><item><title>Impact of environmental factors in predicting daily severity scores of atopic dermatitis</title><link>https://ghurault.github.io/publication/2021-hurault-impact/</link><pubDate>Wed, 28 Apr 2021 12:00:00 +0000</pubDate><guid>https://ghurault.github.io/publication/2021-hurault-impact/</guid><description/></item><item><title>Computational tools for data-driven personalised medicine for Atopic Dermatitis</title><link>https://ghurault.github.io/talk/computational-tools-for-data-driven-personalised-medicine-for-atopic-dermatitis/</link><pubDate>Mon, 19 Apr 2021 10:47:12 +0100</pubDate><guid>https://ghurault.github.io/talk/computational-tools-for-data-driven-personalised-medicine-for-atopic-dermatitis/</guid><description/></item><item><title>Immunoinflammatory Biomarkers in Serum Are Associated with Disease Severity in Atopic Dermatitis</title><link>https://ghurault.github.io/publication/2021-holm-immunoinflammatory/</link><pubDate>Fri, 19 Mar 2021 12:00:00 +0000</pubDate><guid>https://ghurault.github.io/publication/2021-holm-immunoinflammatory/</guid><description/></item><item><title>Stratum corneum markers of innate and T helper cell-related immunity and their relation to the disease severity in Croatian patients with atopic dermatitis</title><link>https://ghurault.github.io/publication/2021-jurakictoncic-stratum/</link><pubDate>Thu, 21 Jan 2021 12:00:00 +0000</pubDate><guid>https://ghurault.github.io/publication/2021-jurakictoncic-stratum/</guid><description/></item><item><title>EczemaNet: Automating Detection and Severity Assessment of Atopic Dermatitis</title><link>https://ghurault.github.io/publication/2020-pan-eczemanet/</link><pubDate>Mon, 17 Aug 2020 10:53:14 +0100</pubDate><guid>https://ghurault.github.io/publication/2020-pan-eczemanet/</guid><description/></item><item><title>miRNA analysis of Childhood Atopic Dermatitis reveals a role for miR-451a</title><link>https://ghurault.github.io/publication/2020-nousbeck-mirna/</link><pubDate>Tue, 02 Jun 2020 08:49:43 +0100</pubDate><guid>https://ghurault.github.io/publication/2020-nousbeck-mirna/</guid><description/></item><item><title>Personalised prediction of daily eczema severity scores using a mechanistic machine learning model</title><link>https://ghurault.github.io/publication/2020-hurault-personalised/</link><pubDate>Sat, 18 Jan 2020 12:00:00 +0100</pubDate><guid>https://ghurault.github.io/publication/2020-hurault-personalised/</guid><description/></item><item><title>Streetmaps</title><link>https://ghurault.github.io/project/streetmaps/</link><pubDate>Wed, 08 Jan 2020 00:00:00 +0000</pubDate><guid>https://ghurault.github.io/project/streetmaps/</guid><description/></item><item><title>Football Prediction</title><link>https://ghurault.github.io/project/football-prediction/</link><pubDate>Tue, 26 Nov 2019 00:00:00 +0000</pubDate><guid>https://ghurault.github.io/project/football-prediction/</guid><description/></item><item><title>HuraultMisc</title><link>https://ghurault.github.io/project/huraultmisc/</link><pubDate>Fri, 28 Jun 2019 00:00:00 +0000</pubDate><guid>https://ghurault.github.io/project/huraultmisc/</guid><description/></item><item><title>A Bayesian Hidden Markov model to predict the dynamic evolution of disease severity in eczema</title><link>https://ghurault.github.io/talk/a-bayesian-hidden-markov-model-to-predict-the-dynamic-evolution-of-disease-severity-in-eczema/</link><pubDate>Mon, 27 May 2019 12:00:00 +0100</pubDate><guid>https://ghurault.github.io/talk/a-bayesian-hidden-markov-model-to-predict-the-dynamic-evolution-of-disease-severity-in-eczema/</guid><description/></item><item><title>Calcium imaging</title><link>https://ghurault.github.io/project/calcium_imaging_app/</link><pubDate>Wed, 01 May 2019 00:00:00 +0000</pubDate><guid>https://ghurault.github.io/project/calcium_imaging_app/</guid><description/></item><item><title>Lokta-Volterra competition model in Stan</title><link>https://ghurault.github.io/project/lvc_stan/</link><pubDate>Fri, 12 Apr 2019 00:00:00 +0000</pubDate><guid>https://ghurault.github.io/project/lvc_stan/</guid><description/></item><item><title>Regularisation</title><link>https://ghurault.github.io/project/regularisation/</link><pubDate>Thu, 24 Jan 2019 00:00:00 +0000</pubDate><guid>https://ghurault.github.io/project/regularisation/</guid><description/></item><item><title>Systemic and stratum corneum biomarkers of severity in infant AD include markers of innate and Th-related immunity and angiogenesis</title><link>https://ghurault.github.io/publication/2019-mcaleer-systemic/</link><pubDate>Tue, 01 Jan 2019 12:00:00 +0100</pubDate><guid>https://ghurault.github.io/publication/2019-mcaleer-systemic/</guid><description/></item><item><title>Bayesian Modelling to Predict the Evolution of Eczema Severity</title><link>https://ghurault.github.io/talk/bayesian-modelling-to-predict-the-evolution-of-eczema-severity/</link><pubDate>Mon, 29 Oct 2018 12:00:00 +0100</pubDate><guid>https://ghurault.github.io/talk/bayesian-modelling-to-predict-the-evolution-of-eczema-severity/</guid><description/></item><item><title>Bayesian Machine Learning to Predict Short-term Course of Eczema Severity</title><link>https://ghurault.github.io/talk/bayesian-machine-learning-to-predict-short-term-course-of-eczema-severity/</link><pubDate>Fri, 07 Sep 2018 12:00:00 +0100</pubDate><guid>https://ghurault.github.io/talk/bayesian-machine-learning-to-predict-short-term-course-of-eczema-severity/</guid><description/></item><item><title>Relationship and probabilistic stratification of EASI and oSCORAD severity scores for atopic dermatitis</title><link>https://ghurault.github.io/publication/2018-hurault-relationship/</link><pubDate>Tue, 26 Jun 2018 12:00:00 +0100</pubDate><guid>https://ghurault.github.io/publication/2018-hurault-relationship/</guid><description/></item><item><title>Predicting short- and long-term outcomes of a systemic therapy for atopic dermatitis using machine learning methods</title><link>https://ghurault.github.io/talk/predicting-short-and-long-term-outcomes-of-a-systemic-therapy-for-atopic-dermatitis-using-machine-learning-methods/</link><pubDate>Fri, 13 Apr 2018 12:00:00 +0100</pubDate><guid>https://ghurault.github.io/talk/predicting-short-and-long-term-outcomes-of-a-systemic-therapy-for-atopic-dermatitis-using-machine-learning-methods/</guid><description/></item><item><title>How can Machine Learning help our understanding of Atopic Dermatitis?</title><link>https://ghurault.github.io/talk/how-can-machine-learning-help-our-understanding-of-atopic-dermatitis/</link><pubDate>Fri, 01 Dec 2017 12:00:00 +0100</pubDate><guid>https://ghurault.github.io/talk/how-can-machine-learning-help-our-understanding-of-atopic-dermatitis/</guid><description/></item><item><title>Contact me</title><link>https://ghurault.github.io/contact/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://ghurault.github.io/contact/</guid><description/></item></channel></rss>